Hormonal therapy in dermatology

Dermatologic Clinics

Volumn 19, Issue 1, 2001, Pages 169-178

  Shaw, James C ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYPROTERONE ACETATE; FINASTERIDE; FLUTAMIDE; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE;

ACNE; ALOPECIA; HIRSUTISM; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

EID: 0035172233     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70238-2     Document Type: Article

References (62)

1. Beneficial effect of spironolactone on androgenic alopecia
2. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
3. The role of oral contraceptives in the treatment of hyperandrogenic disorders
4. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism
5. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission
6. Outcome of longterm treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
7. Consensus conference on combination oral contraceptives and cardiovascular disease
8. Efficacy and clinical profile of a new oral contraceptive containing norgestimate
9. Predictors of clinical response in hirsute women treated with spironolactone
10. Treatment of hirsutism with the pure antiandrogen flutamide
11. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial
12. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: Results of three multicenter trials
13. Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene
14. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
15. Detection of functional ovarian hyperandrogenism in women with androgen excess
16. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism
17. Comparison of spironolactone-oral contraceptive v. cyproterone acetate-estrogen regimens in the treatment of hirsutism
18. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
19. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism
20. Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism
21. Treatment of hirsutism: Comparisons between different antiandrogens with central and peripheral effects
22. Oral spironolactone improves acne vulgaris and reduces sebum excretion
23. Post-adolescent acne: A review of clinical features
24. Male hormone substance: A prime factor in acne
25. Male hormone stimulation is prerequisite and an incitant in common baldness
26. Testosterone concentrations and oligomenorrhea in women with acne
27. Spironolactone and cimetidine in treatment of acne
28. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports
29. Tolerance of spironolactone
30. The androgen control of sebum production: Studies of subjects with dihydrostestosterone deficiency and complete androgen insensitivity
31. Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism
32. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel
33. Androgen metabolism as it affects hair growth in androgenetic alopecia
34. Finasteride in the treatment of men with androgenetic alopecia: Finasteride male pattern hair loss study group
35. Acne is not associated with abnormal plasma androgens
36. Finasteride in the treatment of men with frontal male pattern hair loss
37. Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor
38. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
39. Genetic basis of endocrine disease: 4. The spectrum of mutation in the androgen receptor gene that causes androgen resistance
40. Oral spironolactone: An effective treatment for acne vulgaris in women
41. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism
42. Prospective randomized study comparing the long acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism
43. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
44. Endocrinologic control of the development and activity of the human sebaceous gland
45. Sebum secretion and urinary fractional 17-ketoskeroid and total 17-hydroxycorticoid excretion in male castrates
46. Treatment of hair loss
47. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial
48. Medical treatment of androgen dependent hirsutism
49. Hirsutism
50. Use of GnRH agonists in the treatment of hyperandrogenism
51. Clinical dose ranging studies with finasteride, a type II 5α-reductase inhibitor, in men with male pattern hair loss
52. Oral contraceptives and breast cancer: Review and meta-analysis
53. Oral contraceptive use and breast cancer risk: A meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use
54. Different levels of 5 α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia
55. Antiandrogen and hormonal treatment of acne
56. Spironolactone in dermatologic therapy
57. Antiandrogen therapy in dermatology
58. Low-dose, adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients
59. Acne therapy
60. Androgen metabolism in sebaceous glands from subjects with and without acne
61. Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin
62. Finasteride in the treatment of hirsutism: New therapeutic perspectives